An analysis of psoriasis hospitalisation in Thailand
Issued Date
2023-05-01
Resource Type
ISSN
03403696
eISSN
1432069X
Scopus ID
2-s2.0-85140849314
Pubmed ID
36308558
Journal Title
Archives of Dermatological Research
Volume
315
Issue
4
Start Page
779
End Page
786
Rights Holder(s)
SCOPUS
Bibliographic Citation
Archives of Dermatological Research Vol.315 No.4 (2023) , 779-786
Suggested Citation
Chaiyabutr C., Silpa-archa N., Wongpraprarut C., Likittanasombat S., Phumariyapong P., Chularojanamontri L. An analysis of psoriasis hospitalisation in Thailand. Archives of Dermatological Research Vol.315 No.4 (2023) , 779-786. 786. doi:10.1007/s00403-022-02429-w Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/82068
Title
An analysis of psoriasis hospitalisation in Thailand
Author's Affiliation
Other Contributor(s)
Abstract
Psoriasis hospitalisation is not frequently reported. The objective of this study was to determine (1) the clinical, laboratory and treatment features of patients with psoriasis hospitalised due to flare-up and (2) other causes of admission of patients with psoriasis. We retrospectively reviewed data on 48 patients admitted due to psoriasis flare-up and 1908 patients with psoriasis admitted due to concomitant illnesses or comorbidities. The study period was 2005–2021. The latter group was compared with 821,804 patients without psoriasis admitted during the period. Of the 48 cases, 37.5% had erythroderma, and 62.5% had generalised pustular psoriasis (GPP). Women (68.8%) predominated, especially in the GPP group (76.7%). The mean age of admission with erythroderma (44.8 years) was higher than for GPP (32.1 years). Infection was the main trigger for psoriasis flare-up (46%). Abnormalities in liver function tests were found in 33.3% of the cases. These abnormalities usually subsided 1–2 months after skin improvement (83.4%). Acitretin was the most prescribed drug for GPP (81.4%), whereas topical treatment alone (50%) was the most frequent erythroderma therapy. Intensive care was needed by 9.3% of patients with GPP. In the psoriasis group admitted due to concomitant illnesses or comorbidities, admission due to digestive and infectious causes was significantly higher for psoriasis patients. Our study showed that trend of psoriasis admission due to disease flare-up was not significantly changed even in the era of biologics. We believed that patient education on avoiding the common precipitating factors of psoriasis flare-up and good self-care is mandatory to reduce the risk of hospitalisation.